UREMIDE

This brand name is authorized in Australia, South Africa

Active ingredients

The drug UREMIDE contains one active pharmaceutical ingredient (API):

1 Furosemide
UNII 7LXU5N7ZO5 - FUROSEMIDE

Furosemide inhibits active chloride transport in the thick ascending limb. Re-absorption of sodium, chloride from the nephron is reduced and a hypotonic or isotonic urine produced. The evidence from many experimental studies suggests that furosemide acts along the entire nephron with the exception of the distal exchange site.

Read about Furosemide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
UREMIDE Tablet Marketing Authorisation Holder MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C03CA01 Furosemide C Cardiovascular system → C03 Diuretics → C03C High-ceiling diuretics → C03CA Sulfonamides, plain
Discover more medicines within C03CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2412Y
Country: ZA Health Products Regulatory Authority Identifier(s): J/18.1/357

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.